European Archives - Page 42 of 983 - European Medical Journal

COVID-19 Vaccination Lowers Risk of Autoimmune Skin Diseases

This study aimed to clarify the impact of COVID-19 infection and vaccination on the risk of developing autoimmune blistering diseases.

Using AI to Track Heart Failure Symptoms and NYHA Classes

Deep learning models accurately extract NYHA classifications and heart failure symptoms from clinical notes, offering a scalable solution for improved patient tracking and care.

Study Reveals Lasting Side Effects of Prostate Cancer Therapy

The study revealed that patients treated for prostate cancer, particularly with radiotherapy, have an elevated risk of developing several severe complications.

Can Quality of Life at Admission Predict Recovery for COPD Pneumonia Patients?

Higher quality of life at admission predicts better outcomes for COPD patients with pneumonia, study shows.

Annual Bone Density Screening Recommended for Lung Transplant Patients to Prevent Osteoporosis

Lung transplant patients should undergo annual bone health screenings using dual-energy X-ray absorptiometry for the first two years post-surgery.

Increased Frailty as an Early Predictor of Dementia Risk

Research shows that frailty increases 4 to 9 years before dementia, marking it as an early indicator. Monitoring frailty could help identify high-risk individuals, supporting preventive dementia strategies.

Social Determinants of Health Contribute to Increased Disease Severity in Children with Sickle Cell Disease

A recent study reveals that social determinants of health, including access to food, transportation, and education, significantly impact disease severity in preschool children with sickle cell disease. Despite evidence-based treatments, these factors contribute to higher hospitalisations and acute care utilisation.

Early Sugar Rationing In Utero Linked to Reduced Diabetes and Hypertension Risk

Limiting sugar intake during early life, including in utero, may significantly reduce the risk of developing Type 2 diabetes and hypertension in adulthood.

New Biomarker Predicts IBD Treatment Outcomes

This study investigated how vedolizumab affects the immune cells circulating in the blood, particularly focusing on which patients responded well to the therapy.

stamp of approval

FDA approves first gene therapy delivered directly to the brain

Discover how PTC Therapeutics’ treatment for a rare and fatal genetic disorder called aromatic l-amino acid decarboxylase (AADC) deficiency reached approval